Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor - Wikidata - wikimedia - TriplyDB

Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor

Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor

http://www.wikidata.org/entity/Q34316845

about

Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.Patterns of Failure Following Multimodal Treatment for Medulloblastoma: Long-Term Follow-up Results at a Single Institution Embryonal tumors with multilayered rosettes in children: the SFCE experience.High-dose chemotherapy with reduced-dose craniospinal radiotherapy in children with newly diagnosed high-risk brain tumor Atypical teratoid/rhabdoid tumors: the need for more active therapeutic measures in younger patients.SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis.Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology.

P2860

Q33408250-08A65CB0-9002-47A3-B115-EC6A7FD2D170 Q34667517-7D9A29C8-9649-429C-8E3D-FF98FBB49AFC Q34829846-6B37FA9C-D707-41DB-8F53-640A8ED6BB4E Q36187109-C0F0047B-DACA-46C3-AEBD-E4F7A1EEADEF Q40464649-83FEAE6A-AE12-4520-A300-6B4F65A482D0 Q42360068-4DB86C2C-94C2-4BB7-B3DD-06BD8B5F5E6E Q44633685-C376BB37-4FF8-4238-9C95-045C95C331BC Q47840177-50AD462B-BCBF-490C-BACC-407FF1CF4DB5 Q48935560-18F5B857-FABE-4379-B08F-211B70C87FE2

P2860

Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor

http://www.wikidata.org/entity/Q34316845

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Reduced-dose craniospinal radi ...... rimitive neuroectodermal tumor

@ast

Reduced-dose craniospinal radi ...... rimitive neuroectodermal tumor

@en

Reduced-dose craniospinal radi ...... rimitive neuroectodermal tumor

@nl

type

label

Reduced-dose craniospinal radi ...... rimitive neuroectodermal tumor

@ast

Reduced-dose craniospinal radi ...... rimitive neuroectodermal tumor

@en

Reduced-dose craniospinal radi ...... rimitive neuroectodermal tumor

@nl

prefLabel

Reduced-dose craniospinal radi ...... rimitive neuroectodermal tumor

@ast

Reduced-dose craniospinal radi ...... rimitive neuroectodermal tumor

@en

Reduced-dose craniospinal radi ...... rimitive neuroectodermal tumor

@nl

P1433

Q34316845-E6437F33-AE4A-4472-B7FB-5E65FD216262

P1476

Q34316845-8458DB04-11D0-4356-9D5D-38B78918CC41

P2093

Q34316845-078357EC-C5E6-4D38-A05F-DD8E6556EAC6

Q34316845-0823A181-1447-4C7D-B21E-25A9CC69C547

Q34316845-18538F57-68CE-4C75-BAAE-1F58EC65B696

Q34316845-2117AD2C-72B2-43A3-880C-E3B4BA92C87B

Q34316845-2140078B-BE3D-49B1-A0C5-82E72D41FAED

Q34316845-2254B1D1-FBA4-4F7E-8766-2C23CBA48F7F

Q34316845-2419EB67-7AB0-444C-A05A-3A5D8C88FCF9

Q34316845-52D26A95-B2F7-47E7-9DE3-7CEF16B2DD32

Q34316845-5783CB74-023F-4AD8-B5CE-0DEAB4614E67

Q34316845-590B296E-60AB-45FC-8A0D-710250334B07

P2860

Q34316845-02EAB574-80A1-473B-ADAC-3BEAA01E33CD

Q34316845-1F9BE47B-6825-448A-AF32-0EFD42B70116

Q34316845-28C8AC90-6270-4614-A7F4-301F5256A331

Q34316845-316F9BE8-05E0-4FD2-9ABD-EA721E44EFFF

Q34316845-4042E078-7095-422C-BBE9-75789CDA7150

Q34316845-4EA8CC5D-CE24-4DDF-A1AF-C625C6062611

Q34316845-7F61FA9C-7029-4526-8E7E-CC3D293F5BC5

Q34316845-82CC203E-6CBD-451B-92A1-4FF4E6E3F8F8

Q34316845-8721A54E-01E5-4017-8CD6-5A7DFB44713B

Q34316845-8EE734AB-07A0-4027-856E-5DB49C7B4C08

P304

Q34316845-01A4503B-CC55-4976-8DE7-1283310752C2

P31

Q34316845-C410E97C-45C0-49C2-A788-B6C1C97E743C

P356

Q34316845-C79AABE3-BF97-45CA-83DB-995482A2A597

P433

Q34316845-BB39FEC0-3B9C-4D0C-AFD5-04A77DBC8B48

P478

Q34316845-BEB58F87-4284-4B3A-831C-06BC6960174E

P577

Q34316845-3EC8654C-F6C2-4F27-A096-902D501794DD

P5875

Q34316845-A9567A26-EC4A-4D9B-B8F8-71FFACC2DAC9

P698

Q34316845-387136D2-19AD-4B25-8DF7-020B97B334BC

P921

Q34316845-0B7ABA5E-A065-4571-A867-4AA98EFA53BF

Q34316845-2004425E-4955-4EB3-A316-C20D0B74E420

Q34316845-B2876027-F7BF-4C2A-96E3-363004D6F980

Q34316845-DEC48D97-7923-42F9-A37B-213DF15AE68D

P932

Q34316845-45046336-B62F-44D7-B05C-0ADDA4522365

P356

KJH.2010.45.2.120

P1433

The Korean Journal of Hematology

P1476

Reduced-dose craniospinal radi ...... rimitive neuroectodermal tumor

@en

P2093

Byung Kyu Cho

http://www.w3.org/2001/XMLSchema#string

Do Hoon Lim

http://www.w3.org/2001/XMLSchema#string

Hee Young Shin

http://www.w3.org/2001/XMLSchema#string

Ho Joon Im

http://www.w3.org/2001/XMLSchema#string

Hong Hoe Koo

http://www.w3.org/2001/XMLSchema#string

Hyo Seop Ahn

http://www.w3.org/2001/XMLSchema#string

Hyoung Jin Kang

http://www.w3.org/2001/XMLSchema#string

Hyung Jin Shin

http://www.w3.org/2001/XMLSchema#string

Jeong Ok Hah

http://www.w3.org/2001/XMLSchema#string

Jong Jin Seo

http://www.w3.org/2001/XMLSchema#string

P2860

Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies

Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study.

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

Medulloblastoma: signalling a change in treatment.

Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

Autologous hematopoietic stem cell transplantation for high-risk brain tumors in children.

Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study

High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.

P304

120-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5045/KJH.2010.45.2.120

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49647562

http://www.w3.org/2001/XMLSchema#string

P698

21120191

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma

radiation therapy

supratentorial primitive neuroectodermal tumor

P932

2983022

http://www.w3.org/2001/XMLSchema#string